Clinical trials
Phase 3 Neuromyelitis Optica trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 3 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 5 |
| Hoffmann-La Roche | 4 |
| Tianjin Medical University General Hospital | 2 |
| Beijing Mabworks Biotech Co., Ltd. | 1 |
| Biocad | 1 |
| Guy's and St Thomas' NHS Foundation Trust | 1 |
| Hospices Civils de Lyon | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| RemeGen Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuromyelitis Optica | 17 |
| Myelitis, Transverse | 5 |
| Optic Neuritis | 5 |
| Demyelinating Diseases | 3 |
| Recurrence | 3 |
| Diffuse Cerebral Sclerosis of Schilder | 1 |
| Encephalomyelitis, Acute Disseminated | 1 |
| Mental Disorders | 1 |
| Multiple Sclerosis | 1 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 1 |
Trials
Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.